Takeda considers selling Osaka headquarters to fund Shire purchase

Takeda Pharmaceutical Co. is considering selling its symbolic Osaka headquarters building to help finance its £46 billion ($60 billion) deal to acquire Irish drugmaker Shire Plc., sources close to the …
( read original story …)


Related Post

Italy – Factors to watch on Oct. 11
views 151
World Indices..... Reuters survey of world bourse ...
Yokohama's zinc levels exceed limits
views 215
Yokohama's tire manufacturing operation in West Po...
Japan Draws Flake Over Freezing Fish For Sapporo F...
views 231
After its raucous move to freeze fish in an ice ri...
Global stocks lower on central bank focus
views 167
Still, foreign exchange markets reacted by pushing...
Filipinos in Japan optimistic about changes Dutert...
views 215
While all eyes are glued on new Philippine Preside...
Tokyo, Hong Kong lead Asia gains but dollar retrea...
views 160
Tokyo and Hong Kong led gains on most markets in A...
Nikkei flat as dollar/yen steadies, on track for g...
views 226
TOKYO, June 23 Japan's Nikkei share average was fl...
WeWork launches China unit with $500 million fundi...
views 192
The announcement follows a similar move unveiled e...
Japan’s fertility crisis is turning into a &...
views 141
That's because institutional knowledge is viewed a...
Japan’s Monex considering to buy cryptocurre...
views 129
Japanese online broker Monex Group Inc (8698.T) sa...